Knowledge is power when living with alzheimers.
Get access to the web’s leading Alzheimer news & insights for as little as 16¢/day.Already a subscriber? Sign in here
Corplex Donepezil Skin Patch Therapy Moves to Phase 1 Trial
A once-weekly transdermal patch delivers the most commonly prescribed treatment for Alzheimer’s disease in a way that is biologically equivalent to taking the medication orally, according to preliminary pilot study results. Corium International conducted the bioequivalence (BE) pilot study on its lead product, Corplex, which delivers donepezil — the same active ingredient found in the orally administrated Aricept
SOUNDS VERY INTERESTING, BUT CAN IT WORK ON PATIENT WHO HAS ALREADY HAD ALZHEIMERS FOR SOME 12 OR SO YEARS PLEASE..
We are sure that is something that they are looking at during this trial.